Select for export Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT2A receptor agonist TCB-2 in male DBA/2J mice No abstract availability was recorded for this entry. Details DOI 10.1016/j.pbb.2023.173703 PubMed 38154589 Copy citation Copy BibTeX Pharmacology Biochemistry and Behavior 2023-12-25 Paul Fletcher, Zhaoxia Li, Xiao Dong Ji, Anh D. Lê OpenAlex Published psilocybin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS) Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/1556-4029.15454 PubMed 38140718 Copy citation Copy BibTeX Journal of Forensic Sciences 2023-12-21 Munchelou M Gomonit, Britni Skillman, Madeleine J. Swortwood OpenAlex Published psilocybinpsilocin PharmacologyToxicity Other More
Select for export Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/17512433.2023.2295997 PubMed 38108102 Copy citation Copy BibTeX Expert Review of Clinical Pharmacology 2023-12-17 Lucas F. Borkel, Jaime Rojas-Hernández, Luis Alberto Henríquez-Hernández, Ángelo Santana, Domingo Jesús Quintana Hernández OpenAlex Published psilocybin AddictionChronic PainWellbeing Clinical Trial More
Select for export Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cncr.35024 PubMed 38105653 Copy citation Copy BibTeX Cancer 2023-12-17 Yvan Beaussant, Elise C. Tarbi, Kabir Nigam, Skye A. Miner, Zachary Sager, Justin J. Sanders OpenAlex Published psilocybin DepressionChronic PainAging Clinical Trial More
Select for export Group psychedelic therapy: empirical estimates of cost-savings and improved access Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1293243 PubMed 38125286 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-12-05 Elliot Marseille, Christopher S. Stauffer, Manish Agrawal, Paul Thambi, Kimberly Roddy, Michael C. Mithoefer OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2023.0012 PubMed 40046866 Copy citation Copy BibTeX Psychedelic Medicine 2023-11-30 Christopher R. Nicholas, David Horton, Julia Malicki, Amelia Baltes, Paul R. Hutson, Randall Brown OpenAlex Published psilocybin AddictionPharmacologyReceptor Pharmacology Other More
Select for export Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1287196 PubMed 38025484 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-11-12 Tor-Morten Kvam, Malin V. Uthaug, Kristoffer Andreas Aamodt Andersen, Birk Berggrav Refsum, Paula Aarseth Tunstad, Lowan H. Stewart OpenAlex Published psilocybin AddictionReceptor PharmacologyClinical Trial Clinical Trial More
Select for export Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland Abstract available at the source but not redistributed here. Read at source. Details DOI 10.17992/lbl.2023.11.766 PubMed 37909445 Copy citation Copy BibTeX Læknablaðið 2023-11-02 Ragnar Olafsson, Karól Kvaran, Kristín Ketilsdóttir, Kolbrún Hallgrímsdóttir, Emil L Sigurðsson, Engilbert Sigurðsson OpenAlex Published psilocybin Chronic PainObservational StudyToxicity Observational Study More
Select for export The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231199112 PubMed 37905369 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-10-30 Kurt Stocker, Matthias Hartmann, Laura Ley, A. Becker, Friederike Holze, Matthias E. Liechti OpenAlex Published psilocybin AnxietyConsciousnessMystical Experience Other More
Select for export The Psychedelic Social Club: a regulatory concept for people who use psychedelics? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/09687637.2023.2276067 Copy citation Copy BibTeX Drugs Education Prevention and Policy 2023-10-29 Henry Harder, Fabian P. Steinmetz, Maja Kohek OpenAlex Published psilocybin Mechanism of ActionToxicity Other More
Select for export Effects of psilocybin, the 5-HT2A receptor agonist TCB-2, and the 5-HT2A receptor antagonist M100907 on visual attention in male mice in the continuous performance test No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-023-06474-9 PubMed 37855864 Copy citation Copy BibTeX Psychopharmacology 2023-10-18 Arya Rahbarnia, Zhaoxia Li, Paul Fletcher OpenAlex Published psilocybin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231205692 PubMed 37842884 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-10-15 Natalia Malikowska-Racia, Maciej Koniewski, Joanna Gołębiowska, Piotr Popik OpenAlex Published psilocybin AnxietyChronic PainPharmacology Animal Study More
Select for export Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2147/ndt.s426193 PubMed 37818448 Copy citation Copy BibTeX Neuropsychiatric Disease and Treatment 2023-09-30 Kwonmok Ko, Ben Carter, Anthony J. Cleare, James Rucker OpenAlex Published psilocybin DepressionChronic PainPersonality Change Clinical Trial More
Select for export Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the “high-risk” addiction patient Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1159843 PubMed 37799400 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-09-19 Taylor Black OpenAlex Published psilocybin AddictionWellbeingSafety Other More
Select for export Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1199642 PubMed 37795509 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-09-18 Sandeep M. Nayak, Hillary Jackson, Nathan D. Sepeda, David S. Mathai, Sara So, Abigail Yaffe OpenAlex Published psilocybin DepressionAnxietyChronic Pain Observational Study More
Select for export Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1215972 PubMed 37795513 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-09-17 Keith G. Heinzerling, Karina Sergi, Micah Linton, Rhianna Rich, Brittany Youssef, Inez Bentancourt OpenAlex Published psilocybin AnxietyAddictionChronic Pain Randomized Controlled Trial More
Select for export American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A7-Year Follow-Up Survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2023.0036 PubMed 40051760 Copy citation Copy BibTeX Psychedelic Medicine 2023-09-17 Brian S. Barnett, Miranda Arakelian, David S. Beebe, Jared Ontko, Connor Riegal, Willie O. Siu OpenAlex Published psilocybin DepressionAddictionChronic Pain Clinical Trial More
Select for export Potential Benefits of Psilocybin for Lupus Pain: A Case Report Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/1573397119666230904150750 PubMed 37670693 Copy citation Copy BibTeX Current Rheumatology Reviews 2023-09-05 Sofia Audrey B. Gonzales, Christine Alexopoulos, Daniel G. Arkfeld OpenAlex Published psilocybin Chronic PainPharmacologyMechanism of Action Case Report More
Select for export Comparison of fragrance and flavor components in non-psilocybin and psilocybin mushrooms using vacuum-assisted headspace high-capacity solid-phase microextraction and gas chromatography-mass spectrometry Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.sampre.2023.100090 Copy citation Copy BibTeX Advances in Sample Preparation 2023-09-01 Shannon L. Thomas, Colton Myers, Kevin A. Schug OpenAlex Published psilocybin Toxicity Clinical Trial More
Select for export P05-02: Assessment of the CYP450 inhibitory activity of psilocybin, psilocin, LSD, 5-MeO-DMT and mescaline: An in vitro study No abstract availability was recorded for this entry. Details DOI 10.1016/s0378-4274(23)00499-x Copy citation Copy BibTeX Toxicology Letters 2023-08-31 A. M. Costa, Mariana Silva-Carvalho, Áurea Madureira-Carvalho, Ricardo Jorge Dinis-Oliveira, D. Dias-da-Silva OpenAlex Published psilocybinpsilocin In Vitro StudyToxicity In Vitro Study More
